Note: Mouseover a species abbreviation on the product page to display the fullname.
How can we help you?
![Flow Cytometry: IgM Antibody (BIG73A) [NBP2-61072] - Obtained with bovine leukocytes](http://images.novusbio.com/fullsize/IgM-Antibody-BIG73A-Flow-Cytometry-NBP2-61072-img0001.jpg "Flow Cytometry: IgM Antibody (BIG73A) [NBP2-61072] - Obtained with bovine leukocytes")
![Neutralization: IL-21 Antibody (MT216G/21.3m) [NBP3-18290] - The neutralizing capacity and ND50 was determined using ELISA andELISpot. A) HEK cells were transfected to express the IL-21 activation pathway with alkaline phosphatase as a reporter. Cells were stimulated in the presence of recombinant human IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After overnight incubation, enzyme activity was measured in ELISA. B) Human peripheral blood mononuclear cells (PBMC) were incubated with recombinant IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After 4 days the IgG-secreting B cells were quantified by ELISpot.](http://images.novusbio.com/fullsize/IL-21-Antibody-MT216G-21-3m-Neutralization-NBP3-18290-img0001.jpg "Neutralization: IL-21 Antibody (MT216G/21.3m) [NBP3-18290] - The neutralizing capacity and ND50 was determined using ELISA andELISpot. A) HEK cells were transfected to express the IL-21 activation pathway with alkaline phosphatase as a reporter. Cells were stimulated in the presence of recombinant human IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After overnight incubation, enzyme activity was measured in ELISA. B) Human peripheral blood mononuclear cells (PBMC) were incubated with recombinant IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After 4 days the IgG-secreting B cells were quantified by ELISpot.")
![Flow Cytometry: CD8 Antibody (LT5A) [NBP2-60944] - Obtained with llama leukocytes](http://images.novusbio.com/fullsize/CD8-Antibody-LT5A-Flow-Cytometry-NBP2-60944-img0001.jpg "Flow Cytometry: CD8 Antibody (LT5A) [NBP2-60944] - Obtained with llama leukocytes")
![Flow Cytometry: CD11a/CD18 Antibody (LT48A) [NBP2-60823] - Obtained with alpaca leukocytes](http://images.novusbio.com/fullsize/CD11a-CD18-Antibody-LT48A-Flow-Cytometry-NBP2-60823-img0001.jpg "Flow Cytometry: CD11a/CD18 Antibody (LT48A) [NBP2-60823] - Obtained with alpaca leukocytes")
![Flow Cytometry: CD4 Antibody (GC1A) [NBP2-60890] - Obtained with caprine leukocytes](http://images.novusbio.com/fullsize/CD4-Antibody-GC1A-Flow-Cytometry-NBP2-60890-img0001.jpg "Flow Cytometry: CD4 Antibody (GC1A) [NBP2-60890] - Obtained with caprine leukocytes")
![Flow Cytometry: CD163 Antibody (LND68A) [NBP2-60845] - Flow cytometric profile obtained with bovine leukocytes.](http://images.novusbio.com/fullsize/CD163-Antibody-LND68A-Flow-Cytometry-NBP2-60845-img0001.jpg "Flow Cytometry: CD163 Antibody (LND68A) [NBP2-60845] - Flow cytometric profile obtained with bovine leukocytes.")
![Flow Cytometry: CD45 Antibody (LT12A) [NBP2-60911] - Flow cytometry analysis using CD45 antibody (LT12A) [NBP2-60911]. Obtained with alpaca leukocytes.](http://images.novusbio.com/fullsize/CD45-Antibody-LT12A-Flow-Cytometry-NBP2-60911-img0001.jpg "Flow Cytometry: CD45 Antibody (LT12A) [NBP2-60911] - Flow cytometry analysis using CD45 antibody (LT12A) [NBP2-60911]. Obtained with alpaca leukocytes.")